Bridgepoint Group (LON:BPT) Price Target Raised to GBX 395

Bridgepoint Group (LON:BPT) had its target price boosted by stock analysts at Citigroup from GBX 360 ($4.84) to GBX 395 ($5.31) in a research report issued on Thursday, MarketBeat Ratings reports. The firm presently has a “buy” rating on the stock. Citigroup’s target price points to a potential upside of 15.09% from the stock’s current price.

A number of other equities analysts also recently commented on BPT. JPMorgan Chase & Co. restated an “overweight” rating and set a GBX 424 ($5.70) price objective on shares of Bridgepoint Group in a research note on Thursday. Deutsche Bank Aktiengesellschaft restated a “hold” rating and set a GBX 345 ($4.64) price objective on shares of Bridgepoint Group in a research note on Monday, July 21st.

Bridgepoint Group Trading Up 0.8%

Bridgepoint Group stock opened at GBX 343.20 ($4.62) on Thursday. The firm has a 50-day moving average of GBX 314.06 and a 200-day moving average of GBX 315.18. Bridgepoint Group has a one year low of GBX 229.20 ($3.08) and a one year high of GBX 410 ($5.51). The company has a debt-to-equity ratio of 12.89, a current ratio of 4.98 and a quick ratio of 3.60. The company has a market cap of £2.83 billion, a price-to-earnings ratio of 62.35, a P/E/G ratio of 0.61 and a beta of 1.72.

Bridgepoint Group Company Profile

Bridgepoint Group plc is a private equity and private credit firm specializing in middle market, small mid cap, small cap, growth capital, buyouts investments, syndicate debt, infrastructure, direct lending and credit opportunities in private credit investments. It prefers to invest in advanced industrials, automation, agricultural sciences, energy transition enablers, business services, financial services, professional services, testing inspection and certification, information services, consumer, digital brands, video games, wellbeing products, health care, pharma and MedTech outsourced services, pharma products, and MedTech Products sectors.